Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCR1 is a G-protein-coupled receptor that binds the chemokine IL-8/CXCL8 with high affinity. It is primarily expressed on neutrophils and mediates their chemotaxis and activation during inflammation. CXCR1 plays a crucial role in the inflammatory response and is implicated in various diseases, including cancer, autoimmune disorders, and acute respiratory distress syndrome. It is a potential therapeutic target for modulating inflammation and tumor microenvironment.
CXCR1 antagonists/blockers inhibit the binding of IL-8/CXCL8 and CXCL6 to the receptor, thereby preventing downstream signaling and reducing neutrophil chemotaxis and activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C Motif Chemokine Receptor 1 (CXCR1).